Intelligence Platform
Patents
Browse 69 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12383540
Compounds that modulates AMPA receptor function
granted patentUS 12318418
Modified adenoviruses
granted patentUS 12263173
PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer
granted patentUS 12144813
PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer
granted patentUS 12053513
Cancer-specific T-cell receptors
granted patentUS 11957677
Cancer treatment using FGFR inhibitors and PLK1 inhibitors
granted patentUS 11850264
Gamma delta T-cell receptor and its ligand
granted patentUS 11725039
Ξ±/Ξ² t-cell receptor and methods of using it
granted patentUS 11471502
Neuroprotective peptide
granted patentUS 11298345
Compounds that modulates AMPA receptor function
granted patentUS 11260185
Pressurized metered dose inhalers and method of manufacture
granted patentUS 11207687
Artificial cells
granted patentUS 11186567
AMPA receptor potentiators
granted patentUS 11180466
2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors
granted patentUS 11083696
Dispersion anaesthetic device
granted patentUS 11078252
T-cell receptor
granted patentUS 10655103
Equine progenitor cells
granted patentUS 10564161
Method for identifying a bacterial infection
granted patentUS 10450285
2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors
granted patentUS 10273218
BCL-3 inhibitors
granted patentUS 10209255
Method for identifying a bacterial infection
granted patentUS 10005810
Process for preparing nucleoside prodrugs
granted patentUS 9981092
Pressurised metered dose inhalers and method of manufacture
granted patentUS 9918986
Methods and compounds for preventing osteoarthritis
granted